ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) earnings date
Jan 25, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 27 days, typically, give or take 4 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Oct 26, 2026 | after close | 26 | 8-K |
| Q2 FY2026 | Mon, Aug 3, 2026 | after close | 34 | 8-K |
| Q1 FY2026 | Mon, Apr 27, 2026 | after close | 27 | 8-K |
| Q4 FY2025 | Mon, Jan 26, 2026 | after close | 26 | 8-K |
| Q3 FY2025 | Mon, Oct 27, 2025 | after close | 27 | 8-K |
| Q2 FY2025 | Mon, Jul 21, 2025 | after close | 21 | 8-K |
| Q1 FY2025 | Mon, Apr 28, 2025 | after close | 28 | 8-K |
| Q4 FY2024 | Mon, Jan 27, 2025 | after close | 27 | 8-K |
What they guided beta
| Q3 FY2026 | "Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 viii AI SUPPORTS – BUT DOES NOT REPLACE – PHYSICAL EXPERIMENTATION DONE IN A LAB AI’s Impact on Drug Discovery is Constrained By The Complexity of Human Biology Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 ix ALEXANDRIA’S PATH FORWARD Maintain a Strong and Flexible Balance Sheet, Significant Liquidity, and Targeted Leverage Steadily Improve Occupancy and Increase NOI, Focusing on Leasing to All Sectors of Our Tenant Base Reduce Capital Spend and Funding Needs while Prioritizing Capital Necessary to Lease S" exhibit |
| Q3 FY2026 | "Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 xiii 2026 SOURCES OF CAPITAL: $1.9B (1) TRANSACTIONS Excludes $1.0B of Junior Subordinated Notes Completed $717M $355M (1) ~ $2.6B Completed & Pending $1.9B Guidance Midpoint $1.55B Completed & Pending is More Than Required Which May Allow Us to Defer Some Proceeds Into 2027 (2) Refer to “ Dispositions and sales of partial interests ” in the Earnings Press Release for additional details." exhibit |
| Q3 FY2026 | "(1) Based on the midpoint of our 2026 guidance range for dispositions and sales of partial interests ." exhibit |
| Q3 FY2026 | "(2) Refer to “Key sources and uses of capital” under “2026 Guidance” in the Earnings Press Release for additional details." exhibit |
| Q3 FY2026 | "Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 xiv ALEXANDRIA’S CONTINUED FOCUS ON REDUCING CAPITAL SPEND AND FUNDING NEEDS WHILE PRIORITIZING CAPITAL NECESSARY TO LEASE SPACE ALEXANDRIA CENTER® FOR LIFE SCIENCE – FENWAY | 421 PARK DRIVE ~ $136 MILLION REDUCTION IN FUTURE CONSTRUCTION SPEND THROUGH EXPECTED SALE TO AN INSTITUTIONAL USER 339,668 RSF; anticipated closing in 4Q26 THE ARSENAL ON THE CHARLES | 311 ARSENAL STREET ~ $220 MILLION REDUCTION IN FUTURE CONSTRUCTION SPEND THROUGH PIVOT TO LOWER- COST ADVANCED TECHNOLOGY USE 339,020 RSF project; 66,859 RSF leased and " exhibit |
| Q2 FY2026 | "Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2026 xi AI’S IMPACT ON DRUG DISCOVERY IS CONSTRAINED BY THE COMPLEXITY OF HUMAN BIOLOGY Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2026 xii ALEXANDRIA’S PATH FORWARD Steadily Improve Occupancy and Increase NOI, Focusing on Leasing to All Sectors of Our Tenant Base Continue to Successfully Manage G&A Maintain Optionality for Future Growth Focused on Megacampus TM Investment Consider Flexible and Opportunistic Share Buyback Plan Maintain a Strong and Flexible Balance Sheet, Significant Liquidity, and Targeted Leverag" exhibit |
| Q2 FY2026 | "(1) Reflects the unsecured senior line of credit and commercial paper at the pro forma maturity date of January 22, 2032 , based on the July 2026 amendment to the unsecured senior line of credit, which extends the maturity date from January 22, 2030 and is expected to become effective in September 2026." exhibit |
| Q2 FY2026 | "Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2026 xv 2026 SOURCES OF CAPITAL: $2.9B (1) DISPOSITIONS, SALES OF PARTIAL INTERESTS, AND OTHER CAPITAL SOURCES $1.33B (2) (3) September 2026 Projected Weighted-Average Completion Date $2.9B Guidance Midpoint (1) $471M $1.10B Refer to “ Dispositions, sales of partial interests, and other capital sources ” in the Earnings Press Release for additional details." exhibit |
| Q2 FY2026 | "(1) Based on the midpoint of our 2026 guidance range for dispositions, sales of partial interests, and other capital sources ." exhibit |
| Q2 FY2026 | "We do not anticipate the issuance of any common equity during the year ending December 31, 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ARE
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ARE
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/ARE/"><img src="https://veritasdata.dev/embed/ARE.svg" alt="ARE earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/ARE/)
Script
<script async src="https://veritasdata.dev/embed/ARE.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ARE"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.